The Cell Therapy Human Raw Materials Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of cell therapy human raw materials has seen notable expansion in the past few years. It is projected to increase from $2.82 billion in 2024 to $3.39 billion in 2025, with a compound annual growth rate (CAGR) of 20.4%.
The Cell Therapy Human Raw Materials market is predicted to reach a size of $7.05 billion by 2029, expanding at a compound annual growth rate (CAGR) of 20.1%.
Download Your Free Sample of the 2025 Cell Therapy Human Raw Materials Market Report and Uncover Key Trends Now!The drivers in the cell therapy human raw materials market are:
• Rising prevalence of chronic diseases
• Growing geriatric population
• High demand for regenerative medicines
• Governmental funding and support and increasing healthcare expenditure.
The cell therapy human raw materials market covered in this report is segmented –
1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions
The trends in the cell therapy human raw materials market are:
• Adoption of allogeneic therapies is influencing the future of the cell therapy human raw materials market.
• Integration of artificial intelligence is becoming a significant trend in this field.
• There is a rise in the utilization of off-the-shelf cell therapies.
• The use of 3D bioprinting technology and the development of hybrid cell therapies are shaping the landscape.
The major players in the cell therapy human raw materials market are:
• Thermo Fisher Scientific Inc.
North America was the largest region in the cell therapy human raw materials market in 2023